Come up with a name for your new list and we'll add to it:
InterValve raised a round of funding on August 14, 2014. Investors include
RiverVest Venture Partners.
InterValve is developing an aortic valvuloplasty balloon for treatment of calcific aortic stenosis. Calcific aortic stenosis is the most common cause of acquired valvular heart disease in the Western …